|
Volumn 32, Issue 8, 2005, Pages 1633-1634
|
Interferon-α (IFN-α) application versus tumor necrosis factor-a antagonism for ocular Behçet's disease: Focusing more on IFN [2] (multiple letters)
a a a a b |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
ALPHA2A INTERFERON;
ANTINUCLEAR ANTIBODY;
CYCLOSPORIN A;
GLUCOCORTICOID;
INFLIXIMAB;
METHOTREXATE;
NEUTRALIZING ANTIBODY;
TUMOR NECROSIS FACTOR ALPHA;
ANTIRHEUMATIC AGENT;
BIOLOGICAL RESPONSE MODIFIER;
MONOCLONAL ANTIBODY;
APHTHOUS ULCER;
BEHCET DISEASE;
BLOOD PRESSURE;
CLINICAL TRIAL;
COMMON COLD;
DIARRHEA;
DRUG EFFICACY;
EYE DISEASE;
FOLLICULITIS;
HASHIMOTO DISEASE;
HUMAN;
LETTER;
NAUSEA;
PRIORITY JOURNAL;
PSORIASIS;
RELAPSE;
TUBERCULOSIS;
UVEITIS;
UVEORETINITIS;
VISUAL ACUITY;
VOMITING;
COMPARATIVE STUDY;
DRUG ANTAGONISM;
NOTE;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
BEHCET SYNDROME;
BIOLOGICAL RESPONSE MODIFIERS;
HUMANS;
INTERFERON-ALPHA;
TUMOR NECROSIS FACTOR-ALPHA;
UVEITIS;
|
EID: 23444446584
PISSN: 0315162X
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (17)
|
References (0)
|